The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Compounding Pharmacy Market Research Report 2024
Synopsis
The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:
A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.
A person may be allergic to one of the ingredients in the commercial version of a drug.
A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.
Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.
The global Compounding Pharmacy market was valued at US$ 11570 million in 2023 and is anticipated to reach US$ 13970 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.
This report aims to provide a comprehensive presentation of the global market for Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounding Pharmacy.
Report Scope
The Compounding Pharmacy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla Pharmacy&Stores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy
Segment by Type
PIA
PAA
CUPM
PDA
SAPM
Segment by Application
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Compounding Pharmacy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example:
A young child may need a small, liquid dose of a drug made only in adult-dosage tablets.
A person may be allergic to one of the ingredients in the commercial version of a drug.
A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients.
Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.
The global Compounding Pharmacy market was valued at US$ 11570 million in 2023 and is anticipated to reach US$ 13970 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.
This report aims to provide a comprehensive presentation of the global market for Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounding Pharmacy.
Report Scope
The Compounding Pharmacy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla Pharmacy&Stores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy
Segment by Type
PIA
PAA
CUPM
PDA
SAPM
Segment by Application
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Compounding Pharmacy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Compounding Pharmacy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PIA
1.2.3 PAA
1.2.4 CUPM
1.2.5 PDA
1.2.6 SAPM
1.3 Market by Application
1.3.1 Global Compounding Pharmacy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Consumers Aged 18 and Younger
1.3.3 Consumers Aged 19 to 44
1.3.4 Consumers Aged 45 to 64
1.3.5 Consumers Aged 65 and Older
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Compounding Pharmacy Market Perspective (2019-2030)
2.2 Compounding Pharmacy Growth Trends by Region
2.2.1 Global Compounding Pharmacy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Compounding Pharmacy Historic Market Size by Region (2019-2024)
2.2.3 Compounding Pharmacy Forecasted Market Size by Region (2025-2030)
2.3 Compounding Pharmacy Market Dynamics
2.3.1 Compounding Pharmacy Industry Trends
2.3.2 Compounding Pharmacy Market Drivers
2.3.3 Compounding Pharmacy Market Challenges
2.3.4 Compounding Pharmacy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Compounding Pharmacy Players by Revenue
3.1.1 Global Top Compounding Pharmacy Players by Revenue (2019-2024)
3.1.2 Global Compounding Pharmacy Revenue Market Share by Players (2019-2024)
3.2 Global Compounding Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Compounding Pharmacy Revenue
3.4 Global Compounding Pharmacy Market Concentration Ratio
3.4.1 Global Compounding Pharmacy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Compounding Pharmacy Revenue in 2023
3.5 Compounding Pharmacy Key Players Head office and Area Served
3.6 Key Players Compounding Pharmacy Product Solution and Service
3.7 Date of Enter into Compounding Pharmacy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Compounding Pharmacy Breakdown Data by Type
4.1 Global Compounding Pharmacy Historic Market Size by Type (2019-2024)
4.2 Global Compounding Pharmacy Forecasted Market Size by Type (2025-2030)
5 Compounding Pharmacy Breakdown Data by Application
5.1 Global Compounding Pharmacy Historic Market Size by Application (2019-2024)
5.2 Global Compounding Pharmacy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Compounding Pharmacy Market Size (2019-2030)
6.2 North America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Compounding Pharmacy Market Size by Country (2019-2024)
6.4 North America Compounding Pharmacy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Compounding Pharmacy Market Size (2019-2030)
7.2 Europe Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Compounding Pharmacy Market Size by Country (2019-2024)
7.4 Europe Compounding Pharmacy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Compounding Pharmacy Market Size (2019-2030)
8.2 Asia-Pacific Compounding Pharmacy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Compounding Pharmacy Market Size by Region (2019-2024)
8.4 Asia-Pacific Compounding Pharmacy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Compounding Pharmacy Market Size (2019-2030)
9.2 Latin America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Compounding Pharmacy Market Size by Country (2019-2024)
9.4 Latin America Compounding Pharmacy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Compounding Pharmacy Market Size (2019-2030)
10.2 Middle East & Africa Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Compounding Pharmacy Market Size by Country (2019-2024)
10.4 Middle East & Africa Compounding Pharmacy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PharMEDium Services
11.1.1 PharMEDium Services Company Detail
11.1.2 PharMEDium Services Business Overview
11.1.3 PharMEDium Services Compounding Pharmacy Introduction
11.1.4 PharMEDium Services Revenue in Compounding Pharmacy Business (2019-2024)
11.1.5 PharMEDium Services Recent Development
11.2 B. Braun Group
11.2.1 B. Braun Group Company Detail
11.2.2 B. Braun Group Business Overview
11.2.3 B. Braun Group Compounding Pharmacy Introduction
11.2.4 B. Braun Group Revenue in Compounding Pharmacy Business (2019-2024)
11.2.5 B. Braun Group Recent Development
11.3 Fagron
11.3.1 Fagron Company Detail
11.3.2 Fagron Business Overview
11.3.3 Fagron Compounding Pharmacy Introduction
11.3.4 Fagron Revenue in Compounding Pharmacy Business (2019-2024)
11.3.5 Fagron Recent Development
11.4 Wedgewood Pharmacy
11.4.1 Wedgewood Pharmacy Company Detail
11.4.2 Wedgewood Pharmacy Business Overview
11.4.3 Wedgewood Pharmacy Compounding Pharmacy Introduction
11.4.4 Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.4.5 Wedgewood Pharmacy Recent Development
11.5 New Compounding Pharma
11.5.1 New Compounding Pharma Company Detail
11.5.2 New Compounding Pharma Business Overview
11.5.3 New Compounding Pharma Compounding Pharmacy Introduction
11.5.4 New Compounding Pharma Revenue in Compounding Pharmacy Business (2019-2024)
11.5.5 New Compounding Pharma Recent Development
11.6 Medisca
11.6.1 Medisca Company Detail
11.6.2 Medisca Business Overview
11.6.3 Medisca Compounding Pharmacy Introduction
11.6.4 Medisca Revenue in Compounding Pharmacy Business (2019-2024)
11.6.5 Medisca Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Detail
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Compounding Pharmacy Introduction
11.7.4 Fresenius Kabi Revenue in Compounding Pharmacy Business (2019-2024)
11.7.5 Fresenius Kabi Recent Development
11.8 Advanced Pharma
11.8.1 Advanced Pharma Company Detail
11.8.2 Advanced Pharma Business Overview
11.8.3 Advanced Pharma Compounding Pharmacy Introduction
11.8.4 Advanced Pharma Revenue in Compounding Pharmacy Business (2019-2024)
11.8.5 Advanced Pharma Recent Development
11.9 AIN GROUP
11.9.1 AIN GROUP Company Detail
11.9.2 AIN GROUP Business Overview
11.9.3 AIN GROUP Compounding Pharmacy Introduction
11.9.4 AIN GROUP Revenue in Compounding Pharmacy Business (2019-2024)
11.9.5 AIN GROUP Recent Development
11.10 Nihon Chouzai
11.10.1 Nihon Chouzai Company Detail
11.10.2 Nihon Chouzai Business Overview
11.10.3 Nihon Chouzai Compounding Pharmacy Introduction
11.10.4 Nihon Chouzai Revenue in Compounding Pharmacy Business (2019-2024)
11.10.5 Nihon Chouzai Recent Development
11.11 Sogo Medical
11.11.1 Sogo Medical Company Detail
11.11.2 Sogo Medical Business Overview
11.11.3 Sogo Medical Compounding Pharmacy Introduction
11.11.4 Sogo Medical Revenue in Compounding Pharmacy Business (2019-2024)
11.11.5 Sogo Medical Recent Development
11.12 Dougherty’s Pharmacy
11.12.1 Dougherty’s Pharmacy Company Detail
11.12.2 Dougherty’s Pharmacy Business Overview
11.12.3 Dougherty’s Pharmacy Compounding Pharmacy Introduction
11.12.4 Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.12.5 Dougherty’s Pharmacy Recent Development
11.13 Apollo Pharmacy
11.13.1 Apollo Pharmacy Company Detail
11.13.2 Apollo Pharmacy Business Overview
11.13.3 Apollo Pharmacy Compounding Pharmacy Introduction
11.13.4 Apollo Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.13.5 Apollo Pharmacy Recent Development
11.14 Downing Labs
11.14.1 Downing Labs Company Detail
11.14.2 Downing Labs Business Overview
11.14.3 Downing Labs Compounding Pharmacy Introduction
11.14.4 Downing Labs Revenue in Compounding Pharmacy Business (2019-2024)
11.14.5 Downing Labs Recent Development
11.15 Qol Holdings
11.15.1 Qol Holdings Company Detail
11.15.2 Qol Holdings Business Overview
11.15.3 Qol Holdings Compounding Pharmacy Introduction
11.15.4 Qol Holdings Revenue in Compounding Pharmacy Business (2019-2024)
11.15.5 Qol Holdings Recent Development
11.16 Olympia Pharmacy
11.16.1 Olympia Pharmacy Company Detail
11.16.2 Olympia Pharmacy Business Overview
11.16.3 Olympia Pharmacy Compounding Pharmacy Introduction
11.16.4 Olympia Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.16.5 Olympia Pharmacy Recent Development
11.17 PUMCH
11.17.1 PUMCH Company Detail
11.17.2 PUMCH Business Overview
11.17.3 PUMCH Compounding Pharmacy Introduction
11.17.4 PUMCH Revenue in Compounding Pharmacy Business (2019-2024)
11.17.5 PUMCH Recent Development
11.18 Triangle Compounding Pharmacy
11.18.1 Triangle Compounding Pharmacy Company Detail
11.18.2 Triangle Compounding Pharmacy Business Overview
11.18.3 Triangle Compounding Pharmacy Compounding Pharmacy Introduction
11.18.4 Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.18.5 Triangle Compounding Pharmacy Recent Development
11.19 Peking University First Hospital
11.19.1 Peking University First Hospital Company Detail
11.19.2 Peking University First Hospital Business Overview
11.19.3 Peking University First Hospital Compounding Pharmacy Introduction
11.19.4 Peking University First Hospital Revenue in Compounding Pharmacy Business (2019-2024)
11.19.5 Peking University First Hospital Recent Development
11.20 Affiliated Hospital of Guangdong Public Institution of Medicine
11.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine Company Detail
11.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
11.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Introduction
11.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2019-2024)
11.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
11.21 Lorraine's Pharmacy
11.21.1 Lorraine's Pharmacy Company Detail
11.21.2 Lorraine's Pharmacy Business Overview
11.21.3 Lorraine's Pharmacy Compounding Pharmacy Introduction
11.21.4 Lorraine's Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.21.5 Lorraine's Pharmacy Recent Development
11.22 PLAGH
11.22.1 PLAGH Company Detail
11.22.2 PLAGH Business Overview
11.22.3 PLAGH Compounding Pharmacy Introduction
11.22.4 PLAGH Revenue in Compounding Pharmacy Business (2019-2024)
11.22.5 PLAGH Recent Development
11.23 Institutional Pharmacy Solutions
11.23.1 Institutional Pharmacy Solutions Company Detail
11.23.2 Institutional Pharmacy Solutions Business Overview
11.23.3 Institutional Pharmacy Solutions Compounding Pharmacy Introduction
11.23.4 Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2019-2024)
11.23.5 Institutional Pharmacy Solutions Recent Development
11.24 Ruijin Hospital
11.24.1 Ruijin Hospital Company Detail
11.24.2 Ruijin Hospital Business Overview
11.24.3 Ruijin Hospital Compounding Pharmacy Introduction
11.24.4 Ruijin Hospital Revenue in Compounding Pharmacy Business (2019-2024)
11.24.5 Ruijin Hospital Recent Development
11.25 Belle Sante
11.25.1 Belle Sante Company Detail
11.25.2 Belle Sante Business Overview
11.25.3 Belle Sante Compounding Pharmacy Introduction
11.25.4 Belle Sante Revenue in Compounding Pharmacy Business (2019-2024)
11.25.5 Belle Sante Recent Development
11.26 Byculla Pharmacy&Stores
11.26.1 Byculla Pharmacy&Stores Company Detail
11.26.2 Byculla Pharmacy&Stores Business Overview
11.26.3 Byculla Pharmacy&Stores Compounding Pharmacy Introduction
11.26.4 Byculla Pharmacy&Stores Revenue in Compounding Pharmacy Business (2019-2024)
11.26.5 Byculla Pharmacy&Stores Recent Development
11.27 Royal Chemists
11.27.1 Royal Chemists Company Detail
11.27.2 Royal Chemists Business Overview
11.27.3 Royal Chemists Compounding Pharmacy Introduction
11.27.4 Royal Chemists Revenue in Compounding Pharmacy Business (2019-2024)
11.27.5 Royal Chemists Recent Development
11.28 Village Compounding Pharmacy
11.28.1 Village Compounding Pharmacy Company Detail
11.28.2 Village Compounding Pharmacy Business Overview
11.28.3 Village Compounding Pharmacy Compounding Pharmacy Introduction
11.28.4 Village Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.28.5 Village Compounding Pharmacy Recent Development
11.29 Specialist Pharmacy
11.29.1 Specialist Pharmacy Company Detail
11.29.2 Specialist Pharmacy Business Overview
11.29.3 Specialist Pharmacy Compounding Pharmacy Introduction
11.29.4 Specialist Pharmacy Revenue in Compounding Pharmacy Business (2019-2024)
11.29.5 Specialist Pharmacy Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Compounding Pharmacy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PIA
Table 3. Key Players of PAA
Table 4. Key Players of CUPM
Table 5. Key Players of PDA
Table 6. Key Players of SAPM
Table 7. Global Compounding Pharmacy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Compounding Pharmacy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Compounding Pharmacy Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Compounding Pharmacy Market Share by Region (2019-2024)
Table 11. Global Compounding Pharmacy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Compounding Pharmacy Market Share by Region (2025-2030)
Table 13. Compounding Pharmacy Market Trends
Table 14. Compounding Pharmacy Market Drivers
Table 15. Compounding Pharmacy Market Challenges
Table 16. Compounding Pharmacy Market Restraints
Table 17. Global Compounding Pharmacy Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Compounding Pharmacy Market Share by Players (2019-2024)
Table 19. Global Top Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Pharmacy as of 2023)
Table 20. Ranking of Global Top Compounding Pharmacy Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Compounding Pharmacy Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Compounding Pharmacy Product Solution and Service
Table 24. Date of Enter into Compounding Pharmacy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Compounding Pharmacy Revenue Market Share by Type (2019-2024)
Table 28. Global Compounding Pharmacy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Compounding Pharmacy Revenue Market Share by Type (2025-2030)
Table 30. Global Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Compounding Pharmacy Revenue Market Share by Application (2019-2024)
Table 32. Global Compounding Pharmacy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Compounding Pharmacy Revenue Market Share by Application (2025-2030)
Table 34. North America Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Compounding Pharmacy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Compounding Pharmacy Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Compounding Pharmacy Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
Table 49. PharMEDium Services Company Detail
Table 50. PharMEDium Services Business Overview
Table 51. PharMEDium Services Compounding Pharmacy Product
Table 52. PharMEDium Services Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 53. PharMEDium Services Recent Development
Table 54. B. Braun Group Company Detail
Table 55. B. Braun Group Business Overview
Table 56. B. Braun Group Compounding Pharmacy Product
Table 57. B. Braun Group Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 58. B. Braun Group Recent Development
Table 59. Fagron Company Detail
Table 60. Fagron Business Overview
Table 61. Fagron Compounding Pharmacy Product
Table 62. Fagron Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 63. Fagron Recent Development
Table 64. Wedgewood Pharmacy Company Detail
Table 65. Wedgewood Pharmacy Business Overview
Table 66. Wedgewood Pharmacy Compounding Pharmacy Product
Table 67. Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 68. Wedgewood Pharmacy Recent Development
Table 69. New Compounding Pharma Company Detail
Table 70. New Compounding Pharma Business Overview
Table 71. New Compounding Pharma Compounding Pharmacy Product
Table 72. New Compounding Pharma Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 73. New Compounding Pharma Recent Development
Table 74. Medisca Company Detail
Table 75. Medisca Business Overview
Table 76. Medisca Compounding Pharmacy Product
Table 77. Medisca Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 78. Medisca Recent Development
Table 79. Fresenius Kabi Company Detail
Table 80. Fresenius Kabi Business Overview
Table 81. Fresenius Kabi Compounding Pharmacy Product
Table 82. Fresenius Kabi Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 83. Fresenius Kabi Recent Development
Table 84. Advanced Pharma Company Detail
Table 85. Advanced Pharma Business Overview
Table 86. Advanced Pharma Compounding Pharmacy Product
Table 87. Advanced Pharma Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 88. Advanced Pharma Recent Development
Table 89. AIN GROUP Company Detail
Table 90. AIN GROUP Business Overview
Table 91. AIN GROUP Compounding Pharmacy Product
Table 92. AIN GROUP Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 93. AIN GROUP Recent Development
Table 94. Nihon Chouzai Company Detail
Table 95. Nihon Chouzai Business Overview
Table 96. Nihon Chouzai Compounding Pharmacy Product
Table 97. Nihon Chouzai Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 98. Nihon Chouzai Recent Development
Table 99. Sogo Medical Company Detail
Table 100. Sogo Medical Business Overview
Table 101. Sogo Medical Compounding Pharmacy Product
Table 102. Sogo Medical Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 103. Sogo Medical Recent Development
Table 104. Dougherty’s Pharmacy Company Detail
Table 105. Dougherty’s Pharmacy Business Overview
Table 106. Dougherty’s Pharmacy Compounding Pharmacy Product
Table 107. Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 108. Dougherty’s Pharmacy Recent Development
Table 109. Apollo Pharmacy Company Detail
Table 110. Apollo Pharmacy Business Overview
Table 111. Apollo Pharmacy Compounding Pharmacy Product
Table 112. Apollo Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 113. Apollo Pharmacy Recent Development
Table 114. Downing Labs Company Detail
Table 115. Downing Labs Business Overview
Table 116. Downing Labs Compounding Pharmacy Product
Table 117. Downing Labs Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 118. Downing Labs Recent Development
Table 119. Qol Holdings Company Detail
Table 120. Qol Holdings Business Overview
Table 121. Qol Holdings Compounding Pharmacy Product
Table 122. Qol Holdings Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 123. Qol Holdings Recent Development
Table 124. Olympia Pharmacy Company Detail
Table 125. Olympia Pharmacy Business Overview
Table 126. Olympia Pharmacy Compounding Pharmacy Product
Table 127. Olympia Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 128. Olympia Pharmacy Recent Development
Table 129. PUMCH Company Detail
Table 130. PUMCH Business Overview
Table 131. PUMCH Compounding Pharmacy Product
Table 132. PUMCH Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 133. PUMCH Recent Development
Table 134. Triangle Compounding Pharmacy Company Detail
Table 135. Triangle Compounding Pharmacy Business Overview
Table 136. Triangle Compounding Pharmacy Compounding Pharmacy Product
Table 137. Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 138. Triangle Compounding Pharmacy Recent Development
Table 139. Peking University First Hospital Company Detail
Table 140. Peking University First Hospital Business Overview
Table 141. Peking University First Hospital Compounding Pharmacy Product
Table 142. Peking University First Hospital Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 143. Peking University First Hospital Recent Development
Table 144. Affiliated Hospital of Guangdong Public Institution of Medicine Company Detail
Table 145. Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
Table 146. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product
Table 147. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 148. Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
Table 149. Lorraine's Pharmacy Company Detail
Table 150. Lorraine's Pharmacy Business Overview
Table 151. Lorraine's Pharmacy Compounding Pharmacy Product
Table 152. Lorraine's Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 153. Lorraine's Pharmacy Recent Development
Table 154. PLAGH Company Detail
Table 155. PLAGH Business Overview
Table 156. PLAGH Compounding Pharmacy Product
Table 157. PLAGH Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 158. PLAGH Recent Development
Table 159. Institutional Pharmacy Solutions Company Detail
Table 160. Institutional Pharmacy Solutions Business Overview
Table 161. Institutional Pharmacy Solutions Compounding Pharmacy Product
Table 162. Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 163. Institutional Pharmacy Solutions Recent Development
Table 164. Ruijin Hospital Company Detail
Table 165. Ruijin Hospital Business Overview
Table 166. Ruijin Hospital Compounding Pharmacy Product
Table 167. Ruijin Hospital Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 168. Ruijin Hospital Recent Development
Table 169. Belle Sante Company Detail
Table 170. Belle Sante Business Overview
Table 171. Belle Sante Compounding Pharmacy Product
Table 172. Belle Sante Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 173. Belle Sante Recent Development
Table 174. Byculla Pharmacy&Stores Company Detail
Table 175. Byculla Pharmacy&Stores Business Overview
Table 176. Byculla Pharmacy&Stores Compounding Pharmacy Product
Table 177. Byculla Pharmacy&Stores Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 178. Byculla Pharmacy&Stores Recent Development
Table 179. Royal Chemists Company Detail
Table 180. Royal Chemists Business Overview
Table 181. Royal Chemists Compounding Pharmacy Product
Table 182. Royal Chemists Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 183. Royal Chemists Recent Development
Table 184. Village Compounding Pharmacy Company Detail
Table 185. Village Compounding Pharmacy Business Overview
Table 186. Village Compounding Pharmacy Compounding Pharmacy Product
Table 187. Village Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 188. Village Compounding Pharmacy Recent Development
Table 189. Specialist Pharmacy Company Detail
Table 190. Specialist Pharmacy Business Overview
Table 191. Specialist Pharmacy Compounding Pharmacy Product
Table 192. Specialist Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
Table 193. Specialist Pharmacy Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Compounding Pharmacy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Compounding Pharmacy Market Share by Type: 2023 VS 2030
Figure 3. PIA Features
Figure 4. PAA Features
Figure 5. CUPM Features
Figure 6. PDA Features
Figure 7. SAPM Features
Figure 8. Global Compounding Pharmacy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Compounding Pharmacy Market Share by Application: 2023 VS 2030
Figure 10. Consumers Aged 18 and Younger Case Studies
Figure 11. Consumers Aged 19 to 44 Case Studies
Figure 12. Consumers Aged 45 to 64 Case Studies
Figure 13. Consumers Aged 65 and Older Case Studies
Figure 14. Compounding Pharmacy Report Years Considered
Figure 15. Global Compounding Pharmacy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Compounding Pharmacy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Compounding Pharmacy Market Share by Region: 2023 VS 2030
Figure 18. Global Compounding Pharmacy Market Share by Players in 2023
Figure 19. Global Top Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Pharmacy as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Compounding Pharmacy Revenue in 2023
Figure 21. North America Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Compounding Pharmacy Market Share by Country (2019-2030)
Figure 23. United States Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Compounding Pharmacy Market Share by Country (2019-2030)
Figure 27. Germany Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Compounding Pharmacy Market Share by Region (2019-2030)
Figure 35. China Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Compounding Pharmacy Market Share by Country (2019-2030)
Figure 43. Mexico Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Compounding Pharmacy Market Share by Country (2019-2030)
Figure 47. Turkey Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. PharMEDium Services Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 50. B. Braun Group Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 51. Fagron Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 52. Wedgewood Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 53. New Compounding Pharma Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 54. Medisca Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 55. Fresenius Kabi Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 56. Advanced Pharma Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 57. AIN GROUP Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 58. Nihon Chouzai Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 59. Sogo Medical Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 60. Dougherty’s Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 61. Apollo Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 62. Downing Labs Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 63. Qol Holdings Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 64. Olympia Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 65. PUMCH Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 66. Triangle Compounding Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 67. Peking University First Hospital Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 68. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 69. Lorraine's Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 70. PLAGH Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 71. Institutional Pharmacy Solutions Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 72. Ruijin Hospital Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 73. Belle Sante Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 74. Byculla Pharmacy&Stores Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 75. Royal Chemists Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 76. Village Compounding Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 77. Specialist Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
